Reduce Taxes. Increase Cash Flow. Minimize Risk.
Nationally Ranked Accounting, Valuation and Insurance Groups
Shifts in customer demographics, the Tax Cuts and Jobs Act (TCJA), a rate increase by the Fed, expansion of opportunity zones, an excess of private capital and the rise of online investment platforms, technology advancements, tariffs, and trade disruptions – these are just a few of the storylines defining today’s economic environment and impacting commercial real estate.
Amid these trends, your success in the real estate industry depends in part on your ability to minimize risk, maximize revenue and capitalize on market opportunities.
Working with you from both financial and risk perspectives, the CBIZ Commercial Real Estate Practice takes a consulting approach aimed squarely at helping you achieve those milestones.
Our partnership with Mayer Hoffman McCann P.C. complements our seamless approach to client service - providing a full spectrum of business services and consulting to the real estate industry.
Real Estate Clients and Sectors Served
Our Clients Say It Best
"CBIZ's knowledge of the tax appeal process helped us achieve reductions in real estate taxes that had a real impact on our bottom line."
- Kendall Lees, Real Estate Expense Manager, Kohl's Department Stores
"...a tenant had a large fire in one of the buildings. The CBIZ insurance team was on site even before the fire was fully extinguished. They, along with the CBIZ Valuation Group, served as a valuable advocate throughout the claim negotiations and settlement process."
- Tom Hayes, Risk Management Department, Greensport Industrial Park
"Working with a professional services firm that provides a full range of tax and advisory services has been a great partnership for Takeda. Upon understanding our goals and objectives, [the CBIZ team] was able to recommend additional services to assist in risk management and cost savings, including internal audit services and cost segregation studies."
- Kelly A. Flynn, Associate Director for Real Estate, Takeda Pharmaceuticals